TRAVERE THERAPEUTICS, INC. Increase (Decrease) in Accounts Receivable
TRAVERE THERAPEUTICS, INC. (TVTX) reported Increase (Decrease) in Accounts Receivable of $583.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04
- TRAVERE THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$6.64M, a 255.11% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $7.22M, a 0.29% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$27.82M, a 1502.17% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $44.16M, a 5940.36% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $27.82M, a 363.62% increase from fiscal 2024.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $6.00M, a 46.72% decline from fiscal 2023.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2023 was $11.26M, a 962.64% increase from fiscal 2022.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2022 was $1.06M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $583.00K 10-Q · filed 2026-08-04 | -$27.24M derived: sum of 3 quarters · filed 2026-08-04 | $16.92M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $7.22M 10-Q · filed 2026-05-04 | -$20.59M derived: sum of 2 quarters · filed 2026-05-04 | $23.56M derived: sum of 3 quarters · filed 2026-05-04 | $27.84M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$27.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $16.34M derived: sum of 2 quarters · filed 2026-02-19 | $20.62M derived: sum of 3 quarters · filed 2026-08-04 | $27.82M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $44.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $48.44M derived: sum of 2 quarters · filed 2026-08-04 | $55.64M 10-Q · filed 2025-10-30 | $57.63M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $4.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $11.49M 10-Q · filed 2026-08-04 | $13.47M derived: sum of 3 quarters · filed 2026-08-04 | $14.20M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $7.20M 10-Q · filed 2026-05-04 | $9.19M derived: sum of 2 quarters · filed 2026-05-04 | $9.92M derived: sum of 3 quarters · filed 2026-05-04 | $11.66M derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.71M derived: sum of 2 quarters · filed 2026-02-19 | $4.45M derived: sum of 3 quarters · filed 2026-02-19 | $6.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $731.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.47M derived: sum of 2 quarters · filed 2025-10-30 | $4.02M 10-Q · filed 2025-10-30 | $11.99M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $3.29M 10-Q · filed 2025-08-06 | $11.26M derived: sum of 3 quarters · filed 2026-02-19 | $10.47M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $1.55M 10-Q · filed 2025-05-01 | $9.52M derived: sum of 2 quarters · filed 2026-02-19 | $8.73M derived: sum of 3 quarters · filed 2026-02-19 | $8.15M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $7.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $7.18M derived: sum of 2 quarters · filed 2026-02-19 | $6.61M derived: sum of 3 quarters · filed 2026-02-19 | $11.26M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | -$785.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$1.36M derived: sum of 2 quarters · filed 2024-10-31 | $3.29M 10-Q · filed 2024-10-31 | $9.30M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | -$578.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $4.08M 10-Q · filed 2024-08-01 | $3.73M 10-Q · filed 2023-08-03 | $10.08M derived: sum of 3 quarters · filed 2025-02-21 | $4.36M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2023-03-31 | $4.66M 10-Q · filed 2024-05-06 | $4.89M 10-Q · filed 2023-05-04 | $10.66M derived: sum of 2 quarters · filed 2025-02-21 | $4.94M derived: sum of 3 quarters · filed 2025-02-21 | $6.96M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $283.00K derived: sum of 2 quarters · filed 2025-02-21 | $2.30M derived: sum of 3 quarters · filed 2025-02-21 | $1.06M 10-K · filed 2025-02-21 | $682.00K 10-K · filed 2023-02-23 | |||
| 2022-09-30 | -$5.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$3.70M derived: sum of 2 quarters · filed 2023-11-07 | -$4.94M 10-Q · filed 2023-11-07 | -$3.26M 10-Q · filed 2022-10-27 | -$3.22M derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2022-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $777.00K 10-Q · filed 2023-08-03 | $2.50M derived: sum of 3 quarters · filed 2024-02-20 | $3.98M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | -$1.24M 10-Q · filed 2023-05-04 | $483.00K derived: sum of 2 quarters · filed 2024-02-20 | $1.96M derived: sum of 3 quarters · filed 2024-02-20 | $757.00K derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $3.20M derived: sum of 2 quarters · filed 2024-02-20 | $2.00M derived: sum of 3 quarters · filed 2024-02-20 | -$853.00K 10-K · filed 2024-02-20 | $59.00K 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $274.00K derived: sum of 2 quarters · filed 2022-10-27 | -$2.58M 10-Q · filed 2022-10-27 | -$1.68M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | -$1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$4.06M 10-Q · filed 2022-08-04 | -$3.16M derived: sum of 3 quarters · filed 2023-02-23 | -$2.38M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | -$2.85M 10-Q · filed 2022-05-05 | -$1.96M derived: sum of 2 quarters · filed 2023-02-23 | -$1.17M derived: sum of 3 quarters · filed 2023-02-23 | -$5.21M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $894.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.68M derived: sum of 2 quarters · filed 2023-02-23 | -$2.36M derived: sum of 3 quarters · filed 2023-02-23 | -$2.30M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $784.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$3.26M derived: sum of 2 quarters · filed 2021-10-29 | -$3.19M 10-Q · filed 2021-10-29 | -$2.00M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$3.98M 10-Q · filed 2021-07-29 | -$2.78M derived: sum of 3 quarters · filed 2022-02-24 | -$1.19M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $61.00K 10-Q · filed 2021-05-06 | $1.26M derived: sum of 2 quarters · filed 2022-02-24 | $2.85M derived: sum of 3 quarters · filed 2022-02-24 | $5.29M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.79M derived: sum of 2 quarters · filed 2022-02-24 | $5.22M derived: sum of 3 quarters · filed 2022-02-24 | $5.18M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.03M derived: sum of 2 quarters · filed 2020-11-05 | $3.99M 10-Q · filed 2020-11-05 | $5.18M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $2.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $2.40M 10-Q · filed 2020-07-31 | $3.59M derived: sum of 3 quarters · filed 2021-03-01 | $3.67M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | -$40.00K 10-Q · filed 2020-05-11 | $1.15M derived: sum of 2 quarters · filed 2021-03-01 | $1.24M derived: sum of 3 quarters · filed 2021-03-01 | $694.00K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.28M derived: sum of 2 quarters · filed 2021-03-01 | $734.00K derived: sum of 3 quarters · filed 2021-03-01 | -$152.00K 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$460.00K derived: sum of 2 quarters · filed 2019-10-30 | -$1.35M 10-Q · filed 2019-10-30 | -$2.23M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | -$545.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$1.43M 10-Q · filed 2019-08-06 | -$2.31M derived: sum of 3 quarters · filed 2020-02-24 | -$1.69M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | -$886.00K 10-Q · filed 2019-05-07 | -$1.77M derived: sum of 2 quarters · filed 2020-02-24 | -$1.15M derived: sum of 3 quarters · filed 2020-02-24 | -$2.75M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | -$881.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$260.00K derived: sum of 2 quarters · filed 2020-02-24 | -$1.87M derived: sum of 3 quarters · filed 2020-02-24 | -$4.95M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $621.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$988.00K derived: sum of 2 quarters · filed 2018-11-01 | -$4.06M 10-Q · filed 2018-11-01 | -$518.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$4.68M 10-Q · filed 2018-08-03 | -$1.14M derived: sum of 3 quarters · filed 2019-02-26 | -$2.75M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | -$3.08M 10-Q · filed 2018-07-06 | -$3.10M 10-Q · filed 2017-05-05 | $470.00K derived: sum of 2 quarters · filed 2019-02-26 | -$1.14M derived: sum of 3 quarters · filed 2019-02-26 | $2.09M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.94M derived: sum of 2 quarters · filed 2019-02-26 | $5.16M derived: sum of 3 quarters · filed 2019-02-26 | $6.09M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | -$1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.62M derived: sum of 2 quarters · filed 2017-11-07 | $2.54M 10-Q · filed 2017-11-07 | $2.49M 10-Q · filed 2016-11-04 | $1.51M derived: sum of 4 quarters · filed 2018-07-06 | |||
| 2016-06-30 | $3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $4.15M 10-Q · filed 2017-08-09 | $4.10M 10-Q · filed 2016-08-05 | $3.12M derived: sum of 3 quarters · filed 2018-07-06 | $5.15M derived: sum of 4 quarters · filed 2018-07-06 | |||
| 2016-03-31 | $927.00K 10-Q · filed 2017-05-05 | -$109.00K derived: sum of 2 quarters · filed 2018-07-06 | $1.92M derived: sum of 3 quarters · filed 2018-07-06 | $5.23M derived: sum of 4 quarters · filed 2018-07-06 | ||||
| 2015-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | $996.00K derived: sum of 2 quarters · filed 2018-07-06 | $4.30M derived: sum of 3 quarters · filed 2018-07-06 | $4.50M 10-K · filed 2018-07-06 | ||||
| 2015-09-30 | $2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $5.34M derived: sum of 2 quarters · filed 2016-11-04 | $5.54M 10-Q · filed 2016-11-04 | $8.82M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $3.51M 10-Q · filed 2016-08-05 | $6.79M derived: sum of 3 quarters · filed 2017-03-01 | $9.87M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $203.00K 10-Q · filed 2016-05-05 | $203.12K 10-Q · filed 2015-05-11 | $3.49M derived: sum of 2 quarters · filed 2017-03-01 | $6.56M derived: sum of 3 quarters · filed 2017-03-01 | $8.13M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $6.36M derived: sum of 2 quarters · filed 2017-03-01 | $7.93M derived: sum of 3 quarters · filed 2017-03-01 | $7.96M 10-K · filed 2017-03-01 | $7.96M 10-K · filed 2015-03-11 | |||
| 2014-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $4.65M derived: sum of 2 quarters · filed 2015-11-06 | $4.68M 10-Q · filed 2015-11-06 | $4.68M 10-Q · filed 2014-11-13 | ||||
| 2014-06-30 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.60M 10-Q · filed 2015-08-10 | $1.60M 10-Q · filed 2014-08-14 | |||||
| 2014-03-31 | $28.80K 10-Q · filed 2015-05-11 | |||||||
| 2013-12-31 | $0.00 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |